A retrospective observational study of the natural history of advanced non–small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A retrospective observational study of the natural history of advanced non–small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease
Authors
Keywords
Non–small-cell lung cancer, KRAS, p.G12C, Retrospective
Journal
LUNG CANCER
Volume 159, Issue -, Pages 1-9
Publisher
Elsevier BV
Online
2021-05-25
DOI
10.1016/j.lungcan.2021.05.026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer
- (2021) Kathryn C. Arbour et al. CLINICAL CANCER RESEARCH
- Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project
- (2021) Stephen P. Finn et al. Journal of Thoracic Oncology
- KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
- (2021) Martin Sebastian et al. LUNG CANCER
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).
- (2020) Yutaro Tamiya et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
- (2020) Josiah An et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.
- (2020) Wanyuan Cui et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
- (2020) Stephen V. Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.
- (2020) Alberto Pavan et al. JOURNAL OF CLINICAL ONCOLOGY
- Serine/threonine kinase 11 (STK11) mutations and immunotherapy resistance in patients with non-small cell lung cancer.
- (2020) Richie Uba et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status.
- (2020) Biagio Ricciuti et al. JOURNAL OF CLINICAL ONCOLOGY
- Current therapy of KRAS-mutant lung cancer
- (2020) Aron Ghimessy et al. CANCER AND METASTASIS REVIEWS
- Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
- (2020) Wanyuan Cui et al. LUNG CANCER
- Molecular profiling of non-small cell lung cancer
- (2020) Marika L. Forsythe et al. PLoS One
- 1364P Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
- (2020) F. Griesinger et al. ANNALS OF ONCOLOGY
- Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients
- (2020) Dongsung Kim et al. CELL
- KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
- (2020) David S. Hong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
- (2020) Yi-Long Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations
- (2020) Timothy F. Burns et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
- (2020) Corrin A. Wohlhieter et al. Cell Reports
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
- (2019) Gaurav Singal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways
- (2019) Matthias Scheffler et al. Journal of Thoracic Oncology
- Mutations in the KEAP1-NFE2L2 pathway define a molecular subset of rapidly progressing lung adenocarcinoma
- (2019) Frauke Goeman et al. Journal of Thoracic Oncology
- Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients
- (2019) Youngtae Jeong et al. CLINICAL CANCER RESEARCH
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
- (2019) Jill Hallin et al. Cancer Discovery
- Development and Validation of a High-Quality Composite Real-World Mortality Endpoint
- (2018) Melissa D. Curtis et al. HEALTH SERVICES RESEARCH
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
- (2016) Yijun Tian et al. Journal of Hematology & Oncology
- The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma
- (2016) Anna Biernacka et al. Cancer Genetics
- ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
- (2013) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Observational research — opportunities and limitations
- (2013) Edward J. Boyko JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
- (2012) S. Dogan et al. CLINICAL CANCER RESEARCH
- Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
- (2010) L. M. Solis et al. CLINICAL CANCER RESEARCH
- Recommendations for the assessment of progression in randomised cancer treatment trials
- (2008) J.E. Dancey et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started